Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
an eight-week, multicenter, double-blind, placebo-controlled study evaluating the efficacy, safety and tolerability of one fixed 100 mg dose of Saredutant in patients with Major Depressive Disorder https://kusajili.fr:443/Trial/HgLgGYDHQECmTLgShRX-hA%24an-eight-week-multicenter-double-blind-placebo-controlled-study-evaluating-the-efficacy-safety-and-tolerability-of-one-fixed-10
I have read and accept the terms of use of the site and the Privacy Policy
Send your message